Daniel Rivas, MD
Family Medicine · Burien, WANPI 1811209562
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,634 of the $49,775 with a category attached, or 99.7%. Organon accounts for 98.0% of it on its own, with 1 other manufacturer making up the rest. Among family medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $815.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$49K
- Merck$1K
What the payments were for
- Speaking & faculty fees$49,634100%
- Food & beverage$1410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$48,125
How this compares
$49,775 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 11 | $6,774 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,473 |
| Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf) | 21 | $801 |
| Atorvastatin Calcium | 76 | $637 |
| Lisinopril | 41 | $355 |
| Amlodipine Besylate | 39 | $330 |
| Omeprazole | 13 | $314 |
| Naproxen | 11 | $206 |
| Gabapentin | 16 | $173 |
| Metformin Hcl | 17 | $145 |
| Losartan Potassium | 12 | $140 |
| Metformin Hcl ErMetformin Hcl | 15 | $122 |
| Metoprolol Succinate | 21 | $99 |
| Hydrochlorothiazide | 23 | $82 |
| Rosuvastatin Calcium | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Burien
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
- Greg LedgerwoodBrewster$66K
- Kent WalkerSumner$43K
- Ian BennettSeattle$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.